Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

Summary

This is a two-part, open-label, Phase I/II study in subjects with relapsed or refractory TdT-positive leukemia for which no standard therapies are expected to result in durable remission.

Timeline

Start

2008-06

Primary completion

2010-12

Completion

2010-12

Publications

• Verma AK. Cordycepin: a bioactive metabolite of Cordyceps militaris and polyadenylation inhibitor with therapeutic potential against COVID-19. J Biomol Struct Dyn. 2022 May;40(8):3745-3752. doi: 10.1080/07391102.2020.1850352. Epub 2020 Nov 23.

Drugs

Indications